The cluster is small and mixed, with no insider corroboration. Monitor upcoming earnings for any fundamental catalyst that might explain the modest accumulation by Pzena and Dimensional.
SNY drugs
SNY drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5- T+0 · Nov 4 $47.47entry
- T+1 · 12d ago −1.18%α +3.23% · $46.91
- T+5 · 6d ago +2.02%α +2.94% · $48.43
- T+8 · todayOpen
- T+20 · in 16d Pending
- T+60 · in 3mo Pending
How similar events traded
Executive Summary
Three asset managers increased Sanofi holdings by $5.7M in Q3 2026, led by Pzena more than quadrupling its stake, while two advisors trimmed $5.3M. The net $0.4M inflow is negligible for a $108B market cap, and the 45-day reporting lag limits timeliness.
Key Financial Metrics
Institutional Positions
Net institutional flow: $400.0K
▲ Buyers (3)
| Institution | Action | Change | Position Value | Value Δ |
|---|---|---|---|---|
| Pzena Investment Management | DOUBLED | +348.2% | $4.7M | $3.6M |
| Dimensional Fund Advisors | ADD | +45% | $7.4M | $2.1M |
| Nisa Investment Advisors | ADD | +83.5% | $19.0K | $8.0K |
▼ Sellers (2)
| Institution | Action | Change | Prev Value | Value Δ |
|---|---|---|---|---|
| Kestra Advisory Services | TRIM | -56.4% | $5.9M | -$3.4M |
| Wealth Enhancement Advisory Services | TRIM | -38% | $4.4M | -$1.9M |
Key Facts
- Pzena Investment Management doubled its position, adding $3.6M to reach $4.7M
- Dimensional Fund Advisors added $2.1M, raising its stake to $7.4M
- Kestra Advisory Services trimmed $3.4M, reducing to $2.5M
- Wealth Enhancement Advisory Services trimmed $1.9M, reducing to $2.6M
- Net aggregate change across all five funds was +$0.4M
- No open-market insider buying was detected in the same window
Financial Impact
Three buyers added $5.7M in new positions; two sellers reduced by $5.3M; net inflow of $0.4M, less than 0.001% of market cap
Risk Factors
- 13F data is 45+ days stale; positions may have been unwound since quarter-end
- Net dollar flow is immaterial relative to Sanofi's $108B market cap
- All five funds are asset managers, not activist or event-driven funds, reducing signal strength
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 institutional 13F filing from SEC EDGAR.
| Document | Accession Number |
|---|---|
| INST-CLUSTER Data (Synthetic) | inst-cluster-SNY-2026-Q3 |
Track record
15 reports on SNY
5 of 6 bullish or bearish reports moved the stock their way by T+5. Best: +7.69% at T+60 after the Aug 17, 2026 report. 5 of 6 went positive at some point.
Filters
- Nov 4, 202612d ago Institutional Cluster Neutral 2/10 Viewing Entry $47.47 to $48.43 ▲ +2.02% +2.94% vs SPY
- Oct 30, 202617d ago 6-K Bullish 6/10 Entry $44.34 to $47.04 ▲ +6.09% +8.79% vs SPY
- Oct 26, 202621d ago SC 13G/A Neutral 2/10 Entry $41.89 to $45.33 ▲ +8.21% +10.20% vs SPY
- Oct 26, 202621d ago 6-K Neutral 2/10 Entry $41.79 to $44.34 ▲ +6.10% +7.36% vs SPY
- Oct 1, 20266w ago 6-K Mixed 5/10 Entry $40.67 to $40.23 ▼ −1.08% −2.38% vs SPY
- Sep 17, 20268w ago 6-K Neutral 4/10 Entry $43.14 to $40.94 ▼ −5.10% −5.95% vs SPY
- Aug 31, 202611w ago Court Ruling Neutral 2/10 Entry $44.37 to $42.85 ▼ −3.43% −3.51% vs SPY
- Aug 17, 202613w ago Court Ruling Bullish 4/10 Entry $44.97 to $46.02 ▲ +2.33% +2.54% vs SPY
- Aug 12, 202613w ago Court Ruling Neutral 2/10 Entry $43.78 to $45.15 ▲ +3.13% +5.09% vs SPY
- Jul 31, 202615w ago Court Ruling Bullish 5/10 Entry $42.95 to $43.48 ▲ +1.23% −0.79% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers